Equities researchers at StockNews.com started coverage on shares of Athersys (NASDAQ:ATHX – Get Free Report) in a research note issued on Wednesday. The brokerage set a “hold” rating on the biopharmaceutical company’s stock.
Athersys Stock Performance
The firm has a market capitalization of $833,000.00, a price-to-earnings ratio of -0.01 and a beta of -0.90. Athersys has a 12 month low of $0.01 and a 12 month high of $1.99.
About Athersys
See Also
- Five stocks we like better than Athersys
- Stock Average Calculator
- Matador Resources Insiders Keep Buying Its Stock, Should You?
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- Oracle Can Turn the Magnificent 7 Into 8: Here’s Why
- What Investors Need to Know to Beat the Market
- Palantir Stock Is Up 14% on S&P 500 News: Is It Time to Buy?
Receive News & Ratings for Athersys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Athersys and related companies with MarketBeat.com's FREE daily email newsletter.